압타머 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 25.1%로 80억 3,000만 달러로 성장할 것으로 전망됩니다. 예측기간의 성장은 생명과학에 대한 투자 증가, 의약품 개발 확대, 암 연구 성장, 긴급 환경에서의 신속한 검출, 압타머 선택 기술의 강화, 규제 당국의 지원에 기인합니다. 예측 기간의 주요 동향으로는 셀렉스 기술의 진보, 진단에 있어서의 용도 증가, 압타머 연구에 대한 투자, 나노테크놀로지와의 기술 통합, 계몽·교육 이니셔티브 등이 있습니다.
만성 호흡기 질환의 유병률 증가는 향후 수년간 압타머 시장의 성장을 이끌 것으로 예상됩니다. 만성 호흡기 질환은 기도의 협착과 부종을 특징으로하며, 종종 점액 생산 증가로 이어지고 호흡을 복잡하게하고 기침, 호흡 곤란, 호기시 천명과 같은 증상을 유발합니다. 압타머는 RS 바이러스(RSV)의 검출, 질병의 조기 발견, 치료 보조에 중요한 역할을 합니다. 예를 들어, 2024년 6월 호주 보건복지연구소의 보고에 따르면 2023년 만성폐쇄성 폐질환(COPD)이 전체 질환 부담의 3.6%, 호흡기 질환 관련 50%를 차지했습니다. 게다가 2022년에는 COPD가 7,691명의 사망 원인이었고, 이는 인구 10만명당 29.6명에 해당했으며 호주 전체 사망률의 4.0%를 차지했습니다. 따라서 만성 호흡기 질환의 유병률 증가는 압타머 시장의 성장에 크게 기여합니다.
개인화된 의료가 중요해지면서, 압타머 시장은 앞으로 수년간 크게 성장할 것으로 예측되고 있습니다. 맞춤형 의료는 유전, 라이프스타일, 환경영향 등의 요인을 고려하여 각 환자의 특성에 맞는 치료를 실시함으로써 보다 효과적이고 적정한 헬스케어를 제공하는 것입니다. 이러한 맥락에서 압타머는 표적 진단 및 치료를 위한 맞춤형 분자 도구로서 기능하여 개별 환자의 특정 분자와의 정확한 결합을 가능하게 합니다. 예를 들어, 2022년 FDA는 12건의 개별화 의약품을 새롭게 승인했고 지난 8년간 신약 승인의 적어도 4분의 1을 개별화 의약품이 차지하게 되었습니다. 게다가 FDA는 기존의 맞춤형 치료의 적응을 확대하고, 새롭게 2건의 siRNA 치료를 승인하고, 유전자·세포 기반의 치료법에 대한 가이던스를 발표하고, 5건의 치료법을 승인했습니다. 이와 같이 맞춤형 의료에 대한 관심 증가가 압타머 시장의 성장을 이끌고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 압타머 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인, 성장 억제요인)
- 최종 이용 산업의 분석
- 세계의 압타머 시장 : 성장률 분석
- 세계의 압타머 시장 실적 : 규모와 성장(2019-2024년), 10억 달러
- 세계의 압타머 시장 예측 : 규모와 성장(2024-2029년, 2034년), 10억 달러
- 세계의 압타머 총 주소 가능 시장(TAM)
제6장 시장 세분화
- 세계의 압타머 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- DNA 압타머
- XNA 압타머
- RNA 압타머
- 세계의 압타머 시장 : 기술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- SELEX
- X 압타머
- 마라스 테크닉
- 세계의 압타머 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 치료제 개발
- 연구 및 개발
- 진단
- 기타 용도
- 세계의 압타머 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 제약·바이오테크놀러지 기업
- 학술기관 및 정부연구기관
- 음극선 오실로스코프
- 기타 최종 사용자
- 세계의 압타머 시장 : DNA 압타머의 서브 세분화 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 단일 가닥 DNA(ssDNA) 압타머
- 이중가닥 DNA(dsDNA) 압타머
- 세계의 압타머 시장 : XNA 압타머의 서브 세분화 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 펩타이드 핵산(PNA) 압타머
- 잠긴 핵산(LNA) 압타머
- 글리실 핵산(GNA) 압타머
- 세계의 압타머 시장 : RNA 압타머의 서브 세분화 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 작은 간섭 RNA(siRNA) 압타머
- 짧은 헤어핀 RNA(shRNA) 압타머
- 긴 비코딩 RNA(lncRNA) 압타머
제7장 지역별·국가별 분석
- 세계의 압타머 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 세계의 압타머 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 압타머 시장 : 경쟁 구도
- 압타머 시장 : 기업 프로파일
- Aptamer Group Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- SomaLogic Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Aptamer Sciences Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Aptagen LLC 개요, 제품 및 서비스, 전략 및 재무 분석
- NeoVentures Biotechnology Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Aptus Biotech
- Base Pair Biotechnologies Inc.
- AMS Biotechnology Ltd.
- Vivonics Inc.
- TriLink Biotechnologies LLC
- Noxxon Pharma SE
- AM Biotechnologies LLC
- Raptamer Discovery Group
- Kaneka Corporation
- Novaptech Inc.
- Maravai Lifesciences Inc.
- Bio-Techne Corporation
- Creative Biolabs Inc.
- IBA Lifesciences GmbH
- Aptabharat Innovations Pvt. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 압타머 시장(2029년) : 새로운 기회를 제공하는 국가
- 압타머 시장(2029년) : 새로운 기회를 제공하는 부문
- 압타머 시장(2029년) : 성장 전략
제36장 부록
KTH
Aptamers are short synthetic single-stranded oligonucleotides designed to fold into specific structures and bind to target antigens, which can include proteins, molecules, peptides, cells, and tissues. They serve as molecular recognition tools for their respective targets.
There are various types of aptamers, including DNA aptamers, XNA aptamers, and RNA aptamers. DNA aptamers are specific deoxyribonucleic acid (DNA) oligonucleotides capable of binding with high affinity and specificity to target antigens such as peptides, small molecules, cells, proteins, and tissues. They find applications in the design of drug delivery systems. Technologies like SELEX (Systematic Evolution of Ligands by Exponential Enrichment), X-Aptamer, and MARAS (Mirror-Image Aptamer Reverse Selection) techniques are utilized in therapeutic development, research and development, diagnostics, and other applications. Various end users, including pharmaceutical and biotechnology companies, academic and government research institutes, and diagnostic laboratories, employ aptamers for their diverse applications.
The aptamers market research report is one of a series of new reports from The Business Research Company that provides aptamers market statistics, including aptamers industry global market size, regional shares, competitors with an aptamers market share, detailed aptamers market segments, market trends, and opportunities, and any further data you may need to thrive in the aptamers industry. This aptamers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aptamers market size has grown exponentially in recent years. It will grow from $2.65 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to need for high-specificity binders, therapeutic potential, rise in personalized medicine, potential for therapeutic areas, antibody alternatives, diagnostic point-of-care (POC) devices.
The aptamers market size is expected to see exponential growth in the next few years. It will grow to $8.03 billion in 2029 at a compound annual growth rate (CAGR) of 25.1%. The growth in the forecast period can be attributed to increasing investment in life sciences, expansion in drug development, growth in cancer research, rapid detection in emergency settings, enhanced aptamer selection techniques, regulatory support. Major trends in the forecast period include advancements in selex technology, increasing applications in diagnostics, investment in aptamer research, technological integration with nanotechnology, awareness and education initiatives.
The rising prevalence of chronic respiratory diseases is projected to drive the growth of the aptamers market in the coming years. Chronic respiratory disease is characterized by the narrowing and swelling of airways, often leading to increased mucus production, which complicates breathing and results in symptoms such as coughing, shortness of breath, and wheezing during exhalation. Aptamers play a critical role in detecting the respiratory syncytial virus (RSV), facilitating early disease identification, and aiding in treatment. For example, a report from the Australian Institute of Health and Welfare in June 2024 noted that chronic obstructive pulmonary disease (COPD) accounted for 3.6% of the total disease burden and 50% of the respiratory condition-related burden in 2023. Additionally, in 2022, COPD was the underlying cause of 7,691 deaths, equating to 29.6 per 100,000 population, and representing 4.0% of all deaths in Australia. Thus, the increasing incidence of chronic respiratory diseases is significantly contributing to the growth of the aptamers market.
The growing emphasis on personalized medicine is anticipated to significantly boost the aptamers market in the coming years. Personalized medicine involves tailoring medical treatments to the unique characteristics of each patient, taking into account factors such as genetics, lifestyle, and environmental influences to provide more effective and targeted healthcare. In this context, aptamers serve as customizable molecular tools for targeted diagnostics and therapy, enabling precise binding to specific molecules in individual patients. For example, in 2022, the FDA approved 12 new personalized medicines, which has allowed personalized medicines to account for at least a quarter of new drug approvals for each of the past eight years. Furthermore, the FDA expanded indications for existing personalized therapies, approved two new siRNA therapies, issued guidance on gene and cell-based therapies-approving five such therapies-and introduced new diagnostic indications to facilitate targeted treatment decisions for various health conditions. Consequently, the heightened focus on personalized medicine is driving the growth of the aptamers market.
Technological innovations are key trends gaining traction in the aptamers market. Leading companies in this sector are developing new technologies, such as artificial DNA aptamers, which are created using flexible and advanced methods to maintain their competitive edge. For instance, in August 2023, the FDA approved Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration. Izervay presents a novel option for addressing the progression of geographic atrophy, providing hope to patients affected by this severe form of macular degeneration. This treatment aims to slow the degeneration of retinal cells associated with the condition, representing a significant advancement in vision care.
Prominent players within the aptamers market are spearheading the launch of innovative reagents like Optimer-Fc to tackle challenges prevalent in the immunohistochemistry (IHC) sector. Optimer-Fc represents a groundbreaking reagent designed specifically for automating immunohistochemistry workflows. For instance, in March 2023, UK-based biotech company Aptamer Group plc introduced Optimer-Fc, aimed at revolutionizing automated immunohistochemistry workflows, thereby effectively addressing challenges inherent in the IHC market. The company strategically collaborates with leading IHC firms, conducts meticulous validation of Optimer-Fc's performance, and orchestrates trials in partnership with top-tier pharmaceutical entities. Serving as an alternative to antibodies, Optimer-Fc seamlessly integrates Optimer binders into existing workflows, offering heightened precision and selectivity for disease biomarkers within IHC applications. This innovation assumes significance particularly amid patent expirations for IHC antibodies, presenting a patentable solution to meet evolving market needs.
In a significant development during May 2022, Epicore Biosystems, a US-based digital health and wearable solutions company, executed the acquisition of Eccrine Systems, incorporating its advanced aptamer-based sweat sensing technology into Epicore's array of wearable microfluidic solutions. The acquisition encompasses Eccrine Systems, renowned for its wearable sensor technology and electrochemical aptamer-based technology, enabling the quantification of selected biomarkers within sweat samples. This strategic move bolsters Epicore's sensor technology portfolio, enhancing its capabilities in developing wearable solutions and amplifying its proficiency in leveraging aptamer-based technologies for monitoring targeted biomarkers.
Major companies operating in the aptamers market are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca PLC, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.
North America was the largest region in the aptamers market in 2024. The regions covered in the aptamers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the aptamers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The aptamers market includes revenues earned by entities by providing RNA profiling and detecting cells, viruses, sugars, and antibodies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Aptamers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on aptamers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for aptamers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aptamers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: DNA Aptamers; XNA Aptamers; RNA Aptamers
- 2) By Technology: SELEX; X Aptamer; Maras Technique
- 3) By Application: Therapeutics Development; Research and Development; Diagnostic; Other Applications
- 4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Government Research Institutes; Cathode-Ray Oscilloscope; Other End Users
- Subsegments:
- 1) By DNA Aptamers: Single-Stranded DNA (ssDNA) Aptamers; Double-Stranded DNA (dsDNA) Aptamers
- 2) By XNA Aptamers: Peptide Nucleic Acid (PNA) Aptamers; Locked Nucleic Acid (LNA) Aptamers; Glycyl Nucleic Acid (GNA) Aptamers
- 3) By RNA Aptamers: Small Interfering RNA (siRNA) Aptamers; Short Hairpin RNA (shRNA) Aptamers; Long Non-Coding RNA (lncRNA) Aptamers
- Companies Mentioned: Aptamer Group Limited; SomaLogic Inc.; Aptamer Sciences Inc.; Aptagen LLC; NeoVentures Biotechnology Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Aptamers Market Characteristics
3. Aptamers Market Trends And Strategies
4. Aptamers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Aptamers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Aptamers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Aptamers Market Growth Rate Analysis
- 5.4. Global Aptamers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Aptamers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Aptamers Total Addressable Market (TAM)
6. Aptamers Market Segmentation
- 6.1. Global Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Aptamers
- XNA Aptamers
- RNA Aptamers
- 6.2. Global Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- SELEX
- X Aptamer
- Maras Technique
- 6.3. Global Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Therapeutics Development
- Research and Development
- Diagnostic
- Other Applications
- 6.4. Global Aptamers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical and Biotechnology Companies
- Academic and Government Research Institutes
- Cathode-Ray Oscilloscope
- Other End Users
- 6.5. Global Aptamers Market, Sub-Segmentation Of DNA Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Stranded DNA (ssDNA) Aptamers
- Double-Stranded DNA (dsDNA) Aptamers
- 6.6. Global Aptamers Market, Sub-Segmentation Of XNA Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Peptide Nucleic Acid (PNA) Aptamers
- Locked Nucleic Acid (LNA) Aptamers
- Glycyl Nucleic Acid (GNA) Aptamers
- 6.7. Global Aptamers Market, Sub-Segmentation Of RNA Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Interfering RNA (siRNA) Aptamers
- Short Hairpin RNA (shRNA) Aptamers
- Long Non-Coding RNA (lncRNA) Aptamers
7. Aptamers Market Regional And Country Analysis
- 7.1. Global Aptamers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Aptamers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Aptamers Market
- 8.1. Asia-Pacific Aptamers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Aptamers Market
- 9.1. China Aptamers Market Overview
- 9.2. China Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Aptamers Market
- 10.1. India Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Aptamers Market
- 11.1. Japan Aptamers Market Overview
- 11.2. Japan Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Aptamers Market
- 12.1. Australia Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Aptamers Market
- 13.1. Indonesia Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Aptamers Market
- 14.1. South Korea Aptamers Market Overview
- 14.2. South Korea Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Aptamers Market
- 15.1. Western Europe Aptamers Market Overview
- 15.2. Western Europe Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Aptamers Market
- 16.1. UK Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Aptamers Market
- 17.1. Germany Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Aptamers Market
- 18.1. France Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Aptamers Market
- 19.1. Italy Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Aptamers Market
- 20.1. Spain Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Aptamers Market
- 21.1. Eastern Europe Aptamers Market Overview
- 21.2. Eastern Europe Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Aptamers Market
- 22.1. Russia Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Aptamers Market
- 23.1. North America Aptamers Market Overview
- 23.2. North America Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Aptamers Market
- 24.1. USA Aptamers Market Overview
- 24.2. USA Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Aptamers Market
- 25.1. Canada Aptamers Market Overview
- 25.2. Canada Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Aptamers Market
- 26.1. South America Aptamers Market Overview
- 26.2. South America Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Aptamers Market
- 27.1. Brazil Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Aptamers Market
- 28.1. Middle East Aptamers Market Overview
- 28.2. Middle East Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Aptamers Market
- 29.1. Africa Aptamers Market Overview
- 29.2. Africa Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Aptamers Market Competitive Landscape And Company Profiles
- 30.1. Aptamers Market Competitive Landscape
- 30.2. Aptamers Market Company Profiles
- 30.2.1. Aptamer Group Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. SomaLogic Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Aptamer Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Aptagen LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. NeoVentures Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Aptamers Market Other Major And Innovative Companies
- 31.1. Aptus Biotech
- 31.2. Base Pair Biotechnologies Inc.
- 31.3. AMS Biotechnology Ltd.
- 31.4. Vivonics Inc.
- 31.5. TriLink Biotechnologies LLC
- 31.6. Noxxon Pharma SE
- 31.7. AM Biotechnologies LLC
- 31.8. Raptamer Discovery Group
- 31.9. Kaneka Corporation
- 31.10. Novaptech Inc.
- 31.11. Maravai Lifesciences Inc.
- 31.12. Bio-Techne Corporation
- 31.13. Creative Biolabs Inc.
- 31.14. IBA Lifesciences GmbH
- 31.15. Aptabharat Innovations Pvt. Ltd.
32. Global Aptamers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Aptamers Market
34. Recent Developments In The Aptamers Market
35. Aptamers Market High Potential Countries, Segments and Strategies
- 35.1 Aptamers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Aptamers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Aptamers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
